Upcoming Webinar: Chronic Graft Versus Host Disease (cGVHD) Education and Support

Aug 31, 2018Partners

Chronic Graft Versus Host Disease (cGVHD) Education and Support Webinar

Date and time : Details to follow

We invite you to participate in a FREE webinar that will be sure to help you and your loved ones better understand the complexities of cGVHD as related to cancer treatment and a bone marrow/stem cell transplant.
(Caregivers and the medical community are invited to join this webinar)

Visit us at www.nbmtlink.org
Questions, contact Peggy Burkhard at peggyburkhard@nbmtlink.org
or call 800-546-5268.

Other Entries

Skin GVHD

Skin GVHD

Ready for a mind-blowing statistic? Just one inch of our skin contains almost 20 million cells! That’s hard to imagine, isn’t it? Multiply that to cover an entire body and we each have trillions of skin cells. When GVHD attacks these cells, uncomfortable symptoms like...

Lung GVHD

Lung GVHD

When GVHD affects the lungs, inflammation and scarring of the airways can occur. In its early stages people don’t always notice symptoms — so it’s important to talk to your doctor about proactive pulmonary function testing (PFT) during the first several years after a...

Ocular GVHD

Ocular GVHD

If you are suffering from eye problems after bone marrow transplant — things like dryness, itching, redness, and pain — you might have ocular GVHD. When you receive someone else’s stem cells during a bone or blood marrow transplant, the donor’s cells might mistakenly...

Season 12 of the Marrow Masters Podcast

Season 12 of the Marrow Masters Podcast

Check out the latest season of the Marrow Masters podcast. This season, titled "I'm Home, Now What?" dives into a crucial phase of the journey – the period after returning home. It offers invaluable insights, guidance, and support for individuals who have completed...

Multiple Myeloma Updates – nbmtLINK Lunch & Learn at Noon

Multiple Myeloma Updates – nbmtLINK Lunch & Learn at Noon

This month’s call in program will focus on Multiple Myeloma featuring featuring Dr. C. Ola Landgren, M.D., PhD, Professor of Medicine, Chief of Myeloma Division, Director of the Sylvester Myeloma Institute. Dr. Landgren’s clinical interests include novel therapeutics,...